THERIMUNEX PHARMACEUTICALS INC has a total of 11 patent applications. Its first patent ever was published in 2006. It filed its patents most often in WIPO (World Intellectual Property Organization), Australia and Canada. Its main competitors in its focus markets pharmaceuticals and biotechnology are KENNEDY INST OF RHEUMATOLOGY, EMERGO THERAPEUTICS INC and ANGELICA THERAPEUTICS INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 3 | |
#2 | Australia | 2 | |
#3 | Canada | 1 | |
#4 | China | 1 | |
#5 | EPO (European Patent Office) | 1 | |
#6 | Republic of Korea | 1 | |
#7 | New Zealand | 1 | |
#8 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Biotechnology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Peptides |
# | Name | Total Patents |
---|---|---|
#1 | Thacker James D | 9 |
#2 | Thacker James | 1 |
#3 | Tracker James Douglas | 1 |
#4 | Artlet Carol M | 1 |
Publication | Filing date | Title |
---|---|---|
WO2013134292A2 | Compositions and methods for mitigation of inflammasome activation | |
WO2010118259A1 | Immunologically active lipopeptides and methods for use thereof | |
EP2293809A2 | Peptidyl diacylglycerides | |
US2007197436A1 | Peptidyl diacylglycerides |